Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05689307 · ClinicalTrials.gov registry record · NA
Validation Study With a Non-CE Marked Medical Device (MD)
A NA study of Chronic Cough, sponsored by Siva Health.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05689307: Completed NA study of Chronic Cough, sponsored by Siva Health.
NCT05689307 is a NA study of Chronic Cough that has completed, run by Siva Health. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05689307, a NA study of Chronic Cough, has completed, sponsored by Siva Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This interventional study aims to validate the cough detection device by automatically and continuously measuring the cough frequency with SIVA-MVP among chronic cough patients and in a real-world environment.
Primary Outcome
Validation of a SIVA-MVP performance of detecting individual cough events in a target population over a 24-hour validation phase (first 24 hours after baseline visit). Sensitivity, specificity, and positive and negative predictive values contribute to a description of cough monitor performance.
Conditions Studied
Interventions
- DEVICE SIVA-MVP
Study Locations (1)
Washington
- Bellingham Asthma, Allergy & Immunology Clinic - Bellingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-03-02 |
| Est. Completion | 2024-11-22 |
| Phase | NA |
What the finished NCT05689307 record still lists
NCT05689307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Chronic Cough appearing as the primary indexed condition, and to 1 intervention - of which SIVA-MVP is the first listed.
NCT05689307 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05689307 about?
NCT05689307 is a clinical study titled "Validation Study With a Non-CE Marked Medical Device (MD)". This interventional study aims to validate the cough detection device by automatically and continuously measuring the cough frequency with SIVA-MVP among chronic cough patients and in a real-world environment.
What is the current status of trial NCT05689307?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-03-02. Estimated completion is 2024-11-22.
What conditions does trial NCT05689307 study?
This clinical trial studies the following conditions: Chronic Cough.
What interventions are being tested in trial NCT05689307?
The interventions under investigation include: SIVA-MVP (DEVICE).
Who is sponsoring clinical trial NCT05689307?
This trial is sponsored by Siva Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05689307 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Cough
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05689307's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI